# A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor

> **NCT03499444** · PHASE1 · COMPLETED · sponsor: **pharmaand GmbH** · enrollment: 29 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Rucaparib

## Key facts

- **NCT ID:** NCT03499444
- **Lead sponsor:** pharmaand GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2019-06-18
- **Final completion:** 2022-04-13
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499444, "A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03499444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*